Catalent Pharma Solutions
Articles
Nitrosamines, Elemental Impurities, Extractables, and Leachables: The Pharma Industry’s New Normal
January 31, 2024
Various impurities can infiltrate the container closure system in pharmaceutical manufacturing. Understanding nitrosamines, elemental impurities, extractables, and leachables can help ensure the safety of the final product.
Key Considerations in Using Lipid-Based Formulations: Preclinical Toxicology vs Clinical
January 24, 2024
Lipid-based formulations can improve the oral bioavailability of some molecules. However, a poor understanding of the technology and complexities limit their use.
Process Optimization for mAb Commercial Manufacturing
January 24, 2024
It is essential to have access to the right tools and expertise to support process development for biologic therapies, from the clinical trial phase to commercialization.
Today's Modelling Tools for Small Molecule Solid Dose Manufacturing
September 20, 2023
Modern mathematical and computerized modelling tools can improve scale-up and efficiency of continuous manufacturing of oral solid dosage drugs.
Enabling Successful SDD Scale Up (Sept 2023)
September 01, 2023
A company focused on the treatment of advanced solid tumors, partnered with Catalent for the development, clinical trial supply and scale-up of a spray-drying program.
Formulation and evaluation of enteric coated aspirin capsules. (Sept 2023)
September 01, 2023
Discover how to use enteric polymer coatings effectively for controlled drug delivery in oral medications to enhance your drug formulations.